CERETYPE NEUROMEDICINE
LIVE

Serial Number

88740575

Owner

Ceretype Neuromedicine, Inc.

Attorney

Miguel Danielson

First Use Date

Jul 31, 2023

Filing Date

Dec 27, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CERETYPE NEUROMEDICINE Trademark

Serial Number: 88740575 • Registration: 7202269

CERETYPE NEUROMEDICINE is a trademark filed by Ceretype Neuromedicine, Inc. on December 27, 2019. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Ceretype Neuromedicine, Inc. (2 trademarks)

One Broadway, 14th Floor
Cambridge, MA 02142

Entity Type: 03

Compass Neurosciences, Inc.

Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

December 27, 2019

Registration Date

October 24, 2023

First Use Anywhere

July 31, 2023

First Use in Commerce

July 31, 2023

Published for Opposition

July 7, 2020

Goods & Services

Medical consulting in the field of mental health disorders

Software as a service (SAAS) services featuring functional Magnetic Resonance Imaging (fMRI) for use in mental health disorder diagnosis, treatment and prevention as well as for use in scientific collaboration, sharing and analysis of data and for the presentation and dissemination of results; providing online non-downloadable software for interpreting neuro and brain scans; providing an online non-downloadable integrated suite of fMRI, diagnostic, prevention and treatment software for use in mental health disorder diagnosis, treatment and prevention as well as for use in scientific collaboration, sharing and analysis of data and for the presentation and dissemination of results; analytic and consulting services for the use of neuroimaging technology to improve the utility of non-pharmacological therapeutic interventions for neuropsychiatric disorders; technological consulting and analytical services provided to MRI scanner manufacturers, image analysis companies, functional MRI device companies and academic institutions; pharmaceutical drug development services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 24, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 24, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 22, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 21, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 29, 2023 SUPC
USE AMENDMENT FILED
Aug 26, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 26, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 7, 2023 EXRA
SOU EXTENSION 5 GRANTED
Mar 6, 2023 EX5G
SOU EXTENSION 5 FILED
Feb 27, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 27, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 3, 2022 EXRA
SOU EXTENSION 4 GRANTED
Aug 1, 2022 EX4G
SOU EXTENSION 4 FILED
Aug 1, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 1, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 17, 2022 EXRA
SOU EXTENSION 3 GRANTED
Feb 15, 2022 EX3G
SOU EXTENSION 3 FILED
Feb 15, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 15, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 9, 2021 EXRA
SOU EXTENSION 2 GRANTED
Sep 8, 2021 EX2G
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 1, 2021 ASGN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 24, 2021 AITU
SOU EXTENSION 2 FILED
Aug 20, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 20, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 19, 2021 EXRA
SOU EXTENSION 1 GRANTED
Feb 17, 2021 EX1G
SOU EXTENSION 1 FILED
Feb 17, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 17, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 1, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 15, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 25, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 25, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 25, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 4, 2020 NWOS
NEW APPLICATION ENTERED
Dec 31, 2019 NWAP